American College of Cardiology12d
Discontinuing Drug Treatment in HFrEF, Race and Sacubitril/Valsartan Use in HF, Systolic BP Polygenic Risk Score Treatment Responses
In this week’s View, Dr. Eagle looks at the consequences of discontinuing long-term drug treatment in patients with heart ...
American College of Cardiology5d
Feature | Spotlight on Chest Pain: ACC’s Tools to Support Clinicians and Patients
New to this year's Summit, the Chest Pain Solution Room offered participants of the Chest Pain – MI Registry and Chest Pain Center Accreditation the opportunity to interact with each other in a ...
American College of Cardiology5d
Top Four Trials From TCT 2024: EARLY TAVR, TRISCEND II, ECLIPSE, and CLEAR SYNERGY (OASIS 9)
In this special edition of Eagle’s Eye View, Dr. Eagle looks four of the most important trials presented at the recent TCT Conference: 1) EARLY TAVR evaluating TAVR compared to clinical surveillance; ...
American College of Cardiology6d
Antithrombotic Therapy in High Bleeding Risk for Noncardiac Interventions: Key Points
Galli M, Gragnano F, Berteotti M, et al., on behalf of the Working Group of Thrombosis of the Italian Society of Cardiology. Citation: Antithrombotic Therapy in High Bleeding Risk Part II: Non-Cardiac ...
American College of Cardiology5d
From the Member Sections | The Primary Palliative Care We Already Provide: Supportive Care For CV Patients
You care for a 75-year-old woman with heart failure (HF) with reduced ejection fraction. For the years you have known her, she has enjoyed spending time with her grandchildren, living independently ...
American College of Cardiology5d
Chest Pain – MI Registry: What is the Risk of Ventricular Arrythmia After Primary PCI For STEMI?
A small proportion of patients with STEMI treated via primary PCI experienced late ventricular tachycardia (VT) or ventricular fibrillation (VF), occurring one or more days following the procedure, ...
American College of Cardiology5d
Characteristics of High-Performing Hospitals in Treating Cardiogenic Shock Following AMI
Hospitals with lower risk-adjusted in-hospital mortality rates (RAMR) among patients with cardiogenic shock following acute myocardial infarction (AMI) demonstrated higher rates of revascularization ...
American College of Cardiology5d
New Blood Pressure Target For Individuals at High Risk
Elevated blood pressure is one of the strongest modifiable risk factors for the prevention of cardiovascular (CV) disease. The ESPRIT (Effects of Intensive Systolic Blood Pressure Lower Treatment in ...
American College of Cardiology5d
ACCEL Lite: What Aspects of Cardiovascular Care are Most Primed for Disruption with AI?
Patients can benefit from better healthcare access and outcomes by services that are enabled by artificial intelligence (AI). The current state of technology is evolving to now allow diagnosis of ...
American College of Cardiology12d
Real-time AI to Influence Clinical Decisions and Practice Towards Evidence-based Care: RAPIDxAI Trial
Can algorithms improve the management of patients with myocardial injury? Is there a tool to aid diagnosing patients faster ...
American College of Cardiology5d
Heart of Health Policy | Highlights of Advocacy in Action: ACC 2024 Legislative Conference
An impressive 470 cardiovascular clinicians from across the U.S., took part in ACC's 2024 Legislative Conference in Washington, DC, from Sept. 29 to Oct. 1, where key issues like establishing ...
American College of Cardiology5d
New in Clinical Documents | Perioperative CV Management For Noncardiac Surgery
The newest clinical guideline released by the ACC and American Heart Association (AHA), in collaboration with seven other societies, provides updated recommendations for perioperative cardiovascular ...